Structure Therapeutics (GPCR) Earnings Date & Reports

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

GPCR is expected to report earnings to rise 18.48% to -25 cents per share on May 08

Structure Therapeutics GPCR Stock Earnings Reports

Q1'25

Est.

$-0.25

Q4'24

Beat

by $0.07

Q3'24

Beat

by $0.07

Q2'24

Beat

by $0.06

Q1'24

Beat

by $0.03

The last earnings report on February 27 showed earnings per share of -21 cents, beating the estimate of -28 cents. With 949.91K shares outstanding, the current market capitalization sits at 868.17M.

View a ticker or compare two or three

Compare

GPCR